TipRanks
Go Ultimate55% OFF

InMode (INMDN) Q1 2026 Earnings Report

MX:INMDN Q1 2026 EPS Results

Actual EPS
MXN 4.67
Consensus EPS
MXN 5.57
Beat/Miss
Missed by -MXN 0.90
One Year Ago EPS
MXN 5.79

MX:INMDN Q1 2026 Revenue Results

Actual Revenue
MXN 1.53B
Expected Revenue
MXN 1.49B
Beat/Miss
Beat by +MXN 40.64M
YoY Revenue Growth
+5.32%

Earnings Announcement Details

Quarter
Q1 2026
Date
05/06/2026
Time
Before Open
Conference Call
Wednesday, May 6, 2026
MX:INMDN Upcoming Earnings

InMode's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

Q1 2026 Earnings Call Audio

MX:INMDN Q1 2026 Earnings Call
0:00 / 0:00

Q1 2026 Earnings Slide Deck

Q1 2026 Earnings Call Summary

Q1 2026
Earnings Call Date:May 06, 2026|% Change Since:4.55%|
Earnings Call Sentiment|Neutral

The call contained a mix of modest top-line progress and strategic positives (5% revenue growth, strong cash balance, product launches, sales reorganization and share repurchases) offset by notable margin compression, rising operating expenses and declines in EPS. Management provided steady full-year guidance and described early signs of stabilization in the U.S., but profitability pressures and macroeconomic headwinds temper the outlook. International and product development initiatives offer upside, while near-term margin and demand uncertainty are the primary negatives.

Company Guidance

The company reiterated 2026 guidance calling for revenue of $365–$375 million, non‑GAAP gross margin of 74%–76%, non‑GAAP income from operations of $73–$78 million, and non‑GAAP diluted EPS of $1.33–$1.38; for context, Q1 results included $82.0 million revenue, 75% non‑GAAP gross margin, 17% non‑GAAP operating margin, $0.25 non‑GAAP diluted EPS and $15.4 million cash from operations, while the balance sheet held $537.2 million in cash/marketable securities and the company returned capital via $127.4 million repurchases in 2025 plus $52.7 million year‑to‑date in 2026 (3.86 million shares).

  • Revenue GrowthTotal revenue of $82.0M in Q1 2026, up 5% from $77.9M in Q1 2025, driven primarily by stronger U.S. performance.
  • Solid International Mix and GrowthInternational sales of $38.7M represented 48% of total sales and increased ~2.65% year-over-year; company operates in 100+ countries with Europe performing strongly.
  • Strong Balance Sheet and Cash GenerationCash, cash equivalents, marketable securities and deposits totaled $537.2M as of 3/31/2026; generated $15.4M from operating activities in Q1.
  • Product Momentum — Laser Platforms ContributingNewer platforms (Pico and CO2) made meaningful contributions to Q1 revenue and expand the company’s procedure offering; Erbium laser development targeting FDA clearance by year-end to further broaden portfolio.
  • Sales Organization Changes and Early StabilizationNorth America reorganized to a unified model (new leadership installed end of Q3 2025) and Envision ophthalmology/optometry sales force now operates independently (30 reps); management reports early signs of stabilization, especially in the U.S., with particularly strong progress in March.
  • Capital Return and OptionalitySignificant share repurchases: $127.4M repurchased in 2025 and $52.7M year-to-date under the 2026 program (~3.86M shares YTD); management states all capital allocation options (buybacks, M&A, dividends) remain on the table.
  • Clear 2026 Guidance ProvidedReiterated full-year 2026 guidance: revenue $365M–$375M; non-GAAP gross margin 74%–76%; non-GAAP income from operations $73M–$78M; non-GAAP diluted EPS $1.33–$1.38.

MX:INMDN Earnings History

MX:INMDN earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 11, 20262026 (Q3)6.00-7.1――
Aug 05, 20262026 (Q2)6.206.468.78-26.38% (-2.32)
May 06, 20262026 (Q1)5.574.675.79-19.35% (-1.12)
Feb 10, 20262025 (Q4)7.798.597.859.52% (+0.75)
Nov 05, 20252025 (Q3)6.637.1013.08-45.71% (-5.98)
Jul 30, 20252025 (Q2)7.688.786.3538.24% (+2.43)
Apr 28, 20252025 (Q1)6.615.795.98-3.13% (-0.19)
Feb 04, 20252024 (Q4)9.867.8513.27-40.85% (-5.42)
Oct 30, 20242024 (Q3)10.5913.0811.414.75% (+1.68)
Aug 01, 20242024 (Q2)7.146.3513.45-52.78% (-7.10)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed
Show More